National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Childhood Hodgkin Lymphoma Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 08/04/2008
Table 2. Sample Definitions of Sites and Corresponding Radiation Treatment Fieldsa

Involved Node(s)  Radiation Field 
Cervical Neck and Infraclavicular/Supraclavicularb
Supraclavicular Neck and Infraclavicular/Supraclavicular ± Axilla
Axilla Axilla ± Infraclavicular/Supraclavicular
Mediastinum Mediastinum, Hila, Infraclavicular/Supraclavicularb,c
Hila Hila, Mediastinum
Spleen Spleen ± Para-aortics
Para-aortics Para-aortics ± Spleen
Iliac Ipsilateral Iliac ± Inguinal + Femoral
Inguinal Inguinal + Femoral ± Iliac
Femoral Inguinal + Femoral ± Iliac

aAdapted from Hudson [24]
bUpper cervical region not treated if supraclavicular involvement is extension of the mediastinal disease.
cPrechemotherapy volume is treated except for lateral borders of the mediastinal field, which is postchemotherapy.

References

  1. Hudson M, Constine LS: Hodgkin's disease. In: Halperin EC, Constine LS, Tarbell NJ, et al.: Pediatric Radiation Oncology. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2004, pp 223-60. 


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov